Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06150404
Other study ID # SR-WHTNSS1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 1, 2024
Est. completion date December 2027

Study information

Verified date March 2024
Source Istituto Giannina Gaslini
Contact Silvia Rossi, PhD
Phone 0039 3484929066
Email silviarossi@gaslini.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this Randomized Controlled Trial is to test the efficacy of listening to white noises and parental voices against environmental noise damage in premature babies admitted to the Newborn Intensive Care Unit. The main question it aims to answer is: • Could the combined use of white noises and maternal and/or paternal voices reduce the negative outcomes of continuous exposure to hospital noises on newborns hospitalized in a Neonatal Intensive Care Unit? Participants in the intervention group will listen to a recorded track composed of white noises and voices of their parents who read a story or sing a lullaby from the day of enrollment until the day of discharge, for 4 hours per day. Researchers will compare the intervention group with the control group (who will receive the usual care provided without any intervention on the noise level) to see if babies enrolled in the intervention group show fewer events of tachycardia, tachypnea, desaturation, apnoea, and language or hearing impairment.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 2027
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 31 Weeks and older
Eligibility Inclusion Criteria: - Patients admitted to the NICU with gestational age at birth = 31 weeks (as this is the age at which sound perception is = 40 dB and there is predictable clinical stability to allow intervention delivery without excessive interruptions) - Patients admitted to the NICU who reach gestational age = 31 weeks - Patients monitored with the following types of monitors: Masimo rainbow SET™ (Masimo); Infinity® Delta (Draeger); Infinity® Acute Care System (Draeger); Efficia CM (Philips). Exclusion Criteria: - Patients with gestational age at birth < 31 weeks - Patients affected by meningitis or severe cerebral insults, congenital brain anomalies, congenital syndromes with suspected or known brain dysfunction - Patients diagnosed with hypoxic-ischemic encephalopathy - Patients with significant airway abnormalities resulting in altered breathing during sleep - Patients with terminal illnesses - Patients with congenital anomalies of the face, ears, skull, or brain - Patients with non-bacterial congenital infections - Patients with congenital hearing deficits - Patients whose parents or legal guardians refuse to participate in the study - Patients already enrolled in other clinical studies.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
White Noises and Maternal and/or Paternal voices
The intervention group will receive white noise and maternal and/or paternal voice for a maximum of 4 hours per day, alternated as follows: 1 hour and 30 minutes of white noise, 30 minutes of maternal and/or paternal voice, 1-hour break, 1 hour and 30 minutes of white noise, 30 minutes of maternal and/or paternal voice. The intervention is expected to start at 08:00 in the morning and conclude at 13:00 and will be delivered from the day after the enrollment - when the parents provide their voice recording - until the day of discharge. The device for administering white noise and maternal and/or paternal voice will be placed approximately 30 cm from the head of the infant in the incubator and at the foot of the infant in the open crib. The volume will be 45 dB for infants in incubators and infants in open cribs.

Locations

Country Name City State
Italy IRCCS Istituto Giannina Gaslini Genova

Sponsors (2)

Lead Sponsor Collaborator
Istituto Giannina Gaslini Eubrain

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction of heart rate alteration Reduction, in the patients enrolled in the intervention group compared to the control group, in episodes of heart rate alteration associated with noises > 45 dB (nursing diagnosis: risk of tachycardia - HR >180 bpm - correlated with environmental exposure to noises > 45dB). Through study completion, an average of 2 year
Primary Reduction of oxygen saturation alteration Reduction, in the patients enrolled in the intervention group compared to the control group, in episodes of oxygen saturation alteration associated with noises > 45 dB (nursing diagnosis: risk of desaturation - SpO2 <90% - correlated with environmental exposure to noises > 45dB). Through study completion, an average of 2 year
Primary Reduction of respiratory rate alteration Reduction, in the patients enrolled in the intervention group compared to the control group, in episodes of respiratory rate alteration associated with noises > 45 dB (nursing diagnosis: risk of tachypnoea - RR >60 breaths per minute - correlated with environmental exposure to noises > 45dB). Through study completion, an average of 2 year
Primary Reduction of episodes of apnoea Reduction, in the patients enrolled in the intervention group compared to the control group, in episodes of apnoea associated with noises > 45 dB (nursing diagnosis: risk of apnoea - HR <100 bpm and SpO2 <90% - correlated with environmental exposure to noises > 45dB). Through study completion, an average of 2 year
Secondary Reduction in Language Development Alterations The study will assess whether there is a reduction in language development issues in the intervention group compared to the control group. This evaluation will be conducted during a follow-up assessment at 3 years of age. The nursing diagnosis being considered is "risk of impaired verbal communication related to hospitalization in the NICU." From enrollment unitl 3 years of age
Secondary Reduction in Hearing Development Alterations The study will also assess whether there is a reduction in hearing development issues in the intervention group compared to the control group. These evaluations will be conducted at a follow-up assessment at 3 months of age and any subsequent audiometric examinations. The nursing diagnosis being considered is "risk of compromised hearing development related to hospitalization in the NICU." From enrollment unitl 3 months of age
See also
  Status Clinical Trial Phase
Recruiting NCT05412524 - Impact of Reading on Endogenous Oxytocin System of Preterm Infants N/A
Completed NCT06191757 - Effect Of Early Intervention Program Applied To Premature Infants N/A
Completed NCT04092127 - Pain of Premature Babies and RetCam (DOLICAM)
Completed NCT05729828 - Psychometric Properties of the SMART Feeding Tool
Completed NCT04638127 - PREEMIE PROGRESS: A Family Management Program for Parents of Preterm Infants N/A
Completed NCT02085499 - Flow-synchronized Nasal IMV in Preterm Infants N/A
Recruiting NCT05592210 - Influence and Mechanism of Dyadic Coping on Parenting Stress and Parenting Self-Efficacy in Parents of Preterm Infant
Recruiting NCT06256406 - Effects of Confortable Environment, Kangaroo Care and Music Therapy in Newborns in Neonatal Intensive Care Unit N/A
Active, not recruiting NCT03578341 - Oral Colostrum and Its Effect on Immune System Phase 3
Recruiting NCT05588960 - Investigating Cerebral Oxygenation in the Newborn
Terminated NCT01181791 - Effects of Lactobacillus Reuteri in Premature Infants N/A
Completed NCT04423016 - Transitional Cerebrovascular Reactivity in Very Preterm Infants
Completed NCT05319236 - Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study) N/A
Completed NCT03764813 - Cord Blood Transfusion In Preterm Neonates (CB-TrIP)
Recruiting NCT04902859 - Clonidine as Pain Relief During ROP Eye Examinations Phase 4